TransMedics Group, Inc. — Director's Dealing 2024

May 28, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-05-23

Reporting Person: Gunderson Thomas James (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-23	Common Stock	A	732	$0.00	Acquired	1925	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-23	Stock Option (Right to Buy)	$137.53	A	1154	Acquired	2034-05-23	Common Stock (1154)	Direct

Footnotes

F1: Consists of 732 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2: The option vests in full on the earlier of May 23, 2025 or the date of the 2025 annual meeting of the stockholders of the Issuer, subject to continued service.